An Open-Label Study to Assess the Mass Balance and Metabolic Disposition of an Orally Administered Single Dose of 14C-Labeled Neratinib, an Irreversible pan-ErbB inhibitor, in Healthy Subjects

被引：0
|
作者：
Abbas-Borhan, Richat [1 ]
Chaudhary, Inder [1 ]
Kantrowitz, Joel [1 ]
Hug, Bruce A. [1 ]
Leister, Cathie [1 ]
Burns, Jaime [1 ]
Sonnichsen, Daryl [1 ]
机构：
[1] Pfizer Inc, Collegeville, PA USA
来源：
DRUG METABOLISM REVIEWS | 2010年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：216 / 216
页数：1
相关论文
共 24 条
  • [1] A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects
    Acharya, Milin
    Gonzalez, Martha
    Mannens, Geert
    De Vries, Ronald
    Lopez, Christian
    Griffin, Thomas
    NamPhuong Tran
    [J]. XENOBIOTICA, 2013, 43 (04) : 379 - 389
  • [2] Mass Balance, Metabolic Disposition, Metabolite Characterization, and Pharmacokinetics of Oral 14C-Labeled Bosutinib in Healthy Subjects
    Abbas-Borhan, Richat
    Chaudhary, Inder
    Hug, Bruce A.
    Leister, Cathie
    Burns, Jaime
    Vash-ishtha, Sarvesh
    Erve, John C. L.
    Sonnichsen, Daryl
    [J]. DRUG METABOLISM REVIEWS, 2010, 42 : 228 - 229
  • [3] A phase I, open-label, single-dose micro tracer mass balance study of 14C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry
    Miyatake, Daisuke
    Nakada, Naoyuki
    Takada, Akitsugu
    Kato, Kota
    Taniuchi, Yuta
    Katashima, Masataka
    Sawamoto, Taiji
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (02) : 118 - 124
  • [4] Pharmacokinetics of Orally Administered Single- and Multiple-Dose Olopatadine in Healthy Chinese Subjects An Open-Label Study
    Chu, Nan-Nan
    Chen, Wei-Li
    Xu, Hong-Rong
    Li, Xue-Ning
    [J]. CLINICAL DRUG INVESTIGATION, 2009, 29 (07) : 451 - 457
  • [5] A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects
    Yiming Cheng
    Xiaomin Wang
    Liangang Liu
    Jose Silva
    Michael Thomas
    Yan Li
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2024, 49 : 355 - 365
  • [6] A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects
    Cheng, Yiming
    Wang, Xiaomin
    Liu, Liangang
    Silva, Jose
    Thomas, Michael
    Li, Yan
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (03) : 355 - 365
  • [7] An open-label, single dose study designed to assess the metabolism and mass balance recovery for [14C]-eravacycline in healthy male subjects after oral and intravenous dosing
    Shaw, Iain
    Wood, Stuart
    Mair, Stuart
    Sutcliffe, Joyce A.
    Preskey, Clare
    [J]. DRUG METABOLISM REVIEWS, 2016, 48 : 59 - 59
  • [8] A CLINICAL STUDY TO ASSESS EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS (PK) OF NERATINIB (HKI-272), A PAN-ERBB RECEPTOR TYROSINE KINASE INHIBITOR, WHEN ADMINISTERED CONCOMITANTLY IN HEALTHY SUBJECTS.
    Abbas, R.
    Hug, B.
    Leister, C.
    Sonnichsen, D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S41 - S42
  • [9] Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of 14C-Labeled Isavuconazonium Sulfate in Healthy Male Volunteers
    Townsend, Robert
    Kato, Kota
    Hale, Christine
    Kowalski, Donna
    Lademacher, Christopher
    Yamazaki, Takao
    Akhtar, Shahzad
    Desai, Amit
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (02): : 207 - 216
  • [10] Open-label, single-dose, phase I study evaluating the mass balance and pharmacolkinetics (PKs) of sunitinib (SU) in healthy male subjects
    Sherman, L.
    Peng, G.
    Patyna, S.
    Pool, W.
    Smeraglia, J.
    Bello, C. L.
    Garrett, M.
    Klamerus, K.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 116 - 116
123